Navigation Links
Trans-Atlantic agreement a boost to neuroscience research
Date:5/10/2010

This release is available in French.

Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field. Sir Keith O'Nions, Rector of Imperial, and Heather Munroe-Bloom, Principal and Vice-Chancellor of McGill, met in London to sign the partnership documents, which will consolidate existing scientific collaborations and provide new support for creating a framework for regular academic interactions.

"McGill and Imperial share common interests and strengths in such important fields of transformational research as brain imaging, motor neuron diseases, movement disorders and neuroimmunology," Munroe-Blum said. "I am delighted that the long-standing collaboration between these two leading institutions has been broadened, offering us the opportunity to strengthen and expand our research programs and eventually achieve major advances in our understanding of human neurological disorders."

"The neurosciences are an extremely important and interdisciplinary field of research focused on some of the major health challenges we face today," said Sir Keith. "We are making great strides in understanding how the brain works physically and biochemically, and this work is key to improving mental health. We at Imperial are delighted to have as our partner a leading institution that shares our appetite to carry out excellent research and move it quickly out of the lab to create new therapies for the people who need it."

Neurosciences research is one of McGill's top institutional priorities, building on the distinguished history and current strengths of its Montreal Neurological Institute (MNI) and the Douglas Mental Health University Institute. McGill's integrated program in neurosciences is one of the largest contemporary neuroscience graduate programs in North America. At Imperial, neurosciences research focuses particularly on mechanisms of brain degeneration and restoration of function, systems neuroscience, brain development, pain, anaesthesia, muscular dystrophy, neuroinflammatory disorders such as multiple sclerosis, addiction, molecular neuroimaging, cognitive neuroscience, neurogenetics and various aspects of mental health. Research achievements at the College include the first demonstration that variant CJD is caused by the same prion as BSE.


'/>"/>

Contact: William Raillant-Clark
william.raillant-clark@mcgill.ca
514-398-2189
McGill University
Source:Eurekalert  

Related medicine news :

1. EPA and NASA administrators to extend environmental and Earth science agreement
2. More common ground in health care reform law disagreement than meets the eye
3. BCS Global and Iformata Sign Agreement to Collaborate on the PSVN Initiative to Deliver B2B Video Communications
4. Online Tech and VersaIMAGE Sign SaaS Hosting Agreement
5. VisionQwest Global Group Signs Distribution Agreement with Creative Trade World, Inc.
6. Oridion and Masimo Sign Distribution Agreement to Sell Capnostream™20 Bedside Monitors with the Masimo Patient SafetyNet™ System
7. Online Tech and Healthmaster Sign SaaS Hosting Agreement
8. Stellaris Health Network Hospitals Reach New Agreement with CIGNA HealthCare
9. Sigma-Aldrich Reaches Agreement to Sell Pfizers Bioactive Small Molecule Compounds
10. Historic Agreement Reached to Transition Illinois Residents Unnecessarily Housed in Large, Impersonal Nursing Homes
11. Brain Science Institute announces license agreement to develop treatments for neurological disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Trans-Atlantic agreement a boost to neuroscience research
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th ... Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised ... have been wounded in battle and their families. Venture Construction Group is a 2016 ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology scientists, Dr ... biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm ... on the ASX. Noxopharm is a clinic-ready company with ... 1 clinical study later this year. ... problems facing cancer patients - the ability of cancers to become ...
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: